Ascend Laboratories, LLC 2026-06-17 Health serious FDA
Health · FDA · Recall #FDA-D-0597-2026
Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx… Recall
Issued June 17, 2026 · Ascend Laboratories, LLC
In June 2026, Ascend Laboratories, LLC recalled the Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Dana Whitfield, RecallCheckr
What this means for you
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
What you should do
- 1 Stop using Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Ascend Laboratories, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Ascend Laboratories, LLC
- Category
- Health
- Recall date
- June 17, 2026
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0597-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Ascend Laboratories, LLC has 15 recalls in our database.
- We're tracking 3,707 Health recalls in our database.
- This is the 487th Health recall we've logged in 2026.